Study finds no link between mRNA COVID vaccines early in pregnancy and birth defects
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
-
-
Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
-
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
-
Japan declares a flu epidemic — what this means for other nations
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
-
New Human Liver Organoid Platform Predicts Immune-Mediated Drug Toxicity
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
-
Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
-
WHO warns of widespread resistance to common antibiotics worldwide
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
-
Biotechnology | Diagnostics | Disease | FDA | Neurology | NIH
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
-
New lab-grown human embryo model produces blood cells
On Oct. 13, 2025, University of Cambridge scientists announced they have used human stem cells to create three-dimensional…
-
Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
-
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
-
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
-
Pig liver transplant into a living person edges it closer to the norm
On Oct. 9, 2025, Beicheng Sun at Anhui Medical University in China and his colleagues have reported the…
-
Biotechnology | Disease | Genomics | Oncology
Revolutionary blood test for ME / Chronic Fatigue unveiled
On Oct. 8, 2025, scientists at the University of East Anglia and Oxford Biodynamics announced they have developed a…
-
Biotechnology | Clinical Research | Infectious Disease | Medical Device | Therapeutics | Vaccine | WHO
WHO launches the Global Clinical Trials Forum
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
-
Texas Children’s/Baylor researchers developed new tool to improve accuracy of genetic testing
On Oct. 7, 2025, researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research…
-
St. Jude calculators crunch the numbers to empower survivors of childhood cancer
On Oct. 7, 2025, St. Jude announced that it hosts multiple freely accessible Medical Risk Calculators on the…
-
Bath scientists design peptide ‘switch’ that keeps Parkinson’s protein in its healthy form
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
-
the 2025 Nobel Prize in Physiology or Medicine awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance”
On Oct. 6, 2025, The Nobel Assembly has awarded the Nobel Prize in Physiology or Medicine to Mary E. Brunkow, Fred…
-
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
-
FDA Announces New ANDA Prioritization Pilot to Support U.S. Generic Drug Manufacturing and Testing
On Oct. 3, 2025, the U.S. Food and Drug Administration (FDA) announced a new pilot prioritization program for…
-
First human transplant of kidney modified to have ‘universal’ blood type
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…
-
McGill physicists manoeuvre DNA molecules using electrical fields
On Oct. 2, 2025, researchers in McGill’s Department of Physics announced they have developed a new device that can trap…
-
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 2, 2025, the South Carolina Department of Public Health (DPH) has confirms a measles outbreak in…
-
FDA approved Evita Solution’s generic version of the abortion drug, mifepristone
On Oct. 2, 2025, the U.S. Food and Drug Administration (FDA) approved Evita Solution’s generic version of the…
-
Ancient DNA from horses slaughtered by Neanderthals sheds light on equine evolution
On Oct. 1, 2025, researchers excavating a site known as Schöningen in northern Germany reported finding 300,000-year-old genes,…
-
Mailed HPV test kits are cost-effective for screening
On Oct. 1, 2025, Kaiser Permanente Washington announced results of the first study within a U.S.-based health system…
-
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
On Sept. 30, 2025, Pfizer announced an agreement with the Trump Administration that will ensure U.S. patients pay…
-
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
On Sept. 30, 2025, Zoetis announced that Dectomax®-CA1 Injectable is the first and only parasite control product to…
-
UMass Engineers Create First Artificial Neurons That Could Directly Communicate With Living Cells
On Sept. 30, 2025, a team of engineers at the University of Massachusetts Amherst announced the creation of…
